Analyst Research Report Snapshot


Aurobindo Pharma Limited




MarketLine (a Datamonitor Company)


15 Apr 2014





Companies referenced:


Available for Immediate Download

Aurobindo Pharma Limited Company Profile is the essential source for top-level company data and information. Aurobindo Pharma Limited Company Profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Aurobindo Pharma Limited (APL) develops, manufactures and markets active pharmaceutical ingredients (APIs) and finished dosage formulations. The company develops product in the antibiotics, anti-retroviral, cardiovascular system (CVS), central nervous system (CNS), gastroenterological, anti-diabetics and anti-allergic areas. APL operates in Asia Pacific, Europe, South Africa, Australia and the Americas. It is headquartered in Hyderabad, India and employs around 8,800 people. The company recorded revenues of INR58,553.2 million (approximately $1,078.5 million) in the fiscal year ended March 2013, an increase of 26.5% over 2012. The company's operating profit was INR6,122.1 million (approximately $112.8 million) in fiscal 2013, an increase of 69.7% over 2012. Its net profit was INR2,938.6 million (approximately $54.1 million) in fiscal 2013, as compared to the net loss of INR1,235 million (approximately $22.7 million) in 2012. Scope of the Report - Provides all the crucial information on Aurobindo Pharma Limited required for business and competitor intelligence needs -Data is supplemented with details on Aurobindo Pharma Limited history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Aurobindo Pharma Limited Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Understand prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.